NCT04300439

Brief Summary

Clinical studies on single-use ancillaries are still few; medico-economic benefits have to be assessed regarding their design and use. A foreseeable increase in the number of surgeries in the future, tends to change the techniques and consequently to question the medico-economic context. Single-use ancillaries attempt to provide solutions to today's imperatives and could be relevant from a global medico-economic point of view. For the moment, the conventional ancillaries for TKA are reused after sterilization. The objective of the study is to improve the fluidity of the intervention process with cost control.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 9, 2020

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

March 9, 2020

Status Verified

March 1, 2020

Enrollment Period

3 years

First QC Date

January 16, 2020

Last Update Submit

March 6, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean production cost of the surgical intervention (total knee arthroplasty) each arm, from an hospital perspective, using a micro-costing approach with items reported in a eCRF

    Mean production cost of the surgical intervention in each arm is calculated thanks to 2 steps : 1) Quantification of health resources consumed during the surgical intervention (transport, cleaning, reconditionning sterilization of ancillaries, time spent by medical staff, nurses and materials used. (These data will be collected on a paper sheet and reported in a eCRF for 20 patients (10 per group)) ; 2) Valuation of health resources consumed with hospital cost accounting, mean wages, and purchase prices of materials.

    Day 0

Secondary Outcomes (10)

  • Incremental cost-utility ratio comparing single use ancillary versus reusable ancillary

    1 year

  • clinical functional result in each group (Total KSS score)

    1 year postoperative

  • clinical functional result in each arm

    3 months postoperative

  • HKA angle

    1 year postoperative

  • HKA angle

    3 months postoperative

  • +5 more secondary outcomes

Study Arms (2)

Arm A: metallic reusable ancillary.

ACTIVE COMPARATOR

This control group will be constituted of patients who will have the GMK® prosthesis with metallic reusable ancillary.

Device: knee total arthroplasty with two types of ancillaries

Arm B: Efficiency single use ancillary.

EXPERIMENTAL

This group will be constituted of patients who will have the GMK® prosthesis with Efficiency single use ancillary.

Device: knee total arthroplasty with two types of ancillaries

Interventions

-For the Arm A, the surgical procedure of knee total arthroplasty will be done with metallic reusable ancillary. For the Arm B, the surgical procedure of knee total arthroplasty will be done with Efficiency single use ancillary.

Arm A: metallic reusable ancillary.Arm B: Efficiency single use ancillary.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient with gonarthrosis or inflammatory arthrosis of the knee leading to surgical indication for total knee arthroplasty
  • Informed patient, able to understand the information, not opposing to participate this protocol
  • patient affiliate to social security

You may not qualify if:

  • Extra-joint Deformation needing bone associated gesture
  • Preoperative active or suspected infection
  • Local evolutive tumoral pathology
  • Medical history with bone gesture on concerned knee
  • Patient unable or refusing to give his consentement
  • Pregnant woman or in age to be pregnant without use any effective contraceptive method
  • Patient under maintenance of justice, tutelage or legal guardianship)
  • Presence of any family, sociological, political or geographic situation able to interfere with the protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nantes (University Hospital of Nantes)

Nantes, France

Location

MeSH Terms

Interventions

Arthroplasty, Replacement, Knee

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Mike Persigant, MD

    Nantes University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2020

First Posted

March 9, 2020

Study Start

March 1, 2020

Primary Completion

March 1, 2023

Study Completion

March 1, 2023

Last Updated

March 9, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations